Literature DB >> 28212814

Human Striatal Dopaminergic and Regional Serotonergic Synaptic Degeneration with Lewy Body Disease and Inheritance of APOE ε4.

Nadia Postupna1, Caitlin S Latimer1, Eric B Larson2, Emily Sherfield1, Julie Paladin1, Carol A Shively3, Matthew J Jorgensen3, Rachel N Andrews3, Jay R Kaplan3, Paul K Crane4, Kathleen S Montine1, Suzanne Craft5, C Dirk Keene1, Thomas J Montine6.   

Abstract

Cognitive impairment in older individuals is a complex trait that in population-based studies most commonly derives from an individually varying mixture of Alzheimer disease, Lewy body disease, and vascular brain injury. We investigated the molecular composition of synaptic particles from three sources: consecutive rapid autopsy brains from the Adult Changes in Thought Study, a population-based cohort; four aged nonhuman primate brains optimally processed for molecular investigation; and targeted replacement transgenic mice homozygous for APOE ε4. Our major goal was to characterize the molecular composition of human synaptic particles in regions of striatum and prefrontal cortex. We performed flow cytometry to measure six markers of synaptic subtypes, as well as amyloid β 42 and paired helical filament tau. Our results showed selective degeneration of dopaminergic terminals throughout the striatum in individuals with Lewy body disease, and serotonergic degeneration in human ventromedial caudate nucleus from individuals with an APOE ε4 allele. Similar results were seen in mouse caudate nucleus homozygous for APOE ε4 via targeted replacement. Together, extension of these clinical, pathologic, and genetic associations from tissue to the synaptic compartment of cerebral cortex and striatum strongly supports our approach for accurately observing the molecular composition of human synapses by flow cytometry.
Copyright © 2017 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28212814      PMCID: PMC5397713          DOI: 10.1016/j.ajpath.2016.12.010

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  39 in total

1.  Ecology of the aging human brain.

Authors:  Joshua A Sonnen; Karen Santa Cruz; Laura S Hemmy; Randall Woltjer; James B Leverenz; Kathleen S Montine; Clifford R Jack; Jeffrey Kaye; Kelvin Lim; Eric B Larson; Lon White; Thomas J Montine
Journal:  Arch Neurol       Date:  2011-08

Review 2.  The neurobiological basis of cognitive impairment in Parkinson's disease.

Authors:  Glenda M Halliday; James B Leverenz; Jay S Schneider; Charles H Adler
Journal:  Mov Disord       Date:  2014-04-15       Impact factor: 10.338

3.  Isolation of synaptic terminals from Alzheimer's disease cortex.

Authors:  Sophie Sokolow; Kristen M Henkins; Iris A Williams; Harry V Vinters; Ingrid Schmid; Gregory M Cole; Karen H Gylys
Journal:  Cytometry A       Date:  2011-12-28       Impact factor: 4.355

4.  Drebrin, a dendritic spine protein, is manifold decreased in brains of patients with Alzheimer's disease and Down syndrome.

Authors:  Ki Shuk Shim; Gert Lubec
Journal:  Neurosci Lett       Date:  2002-05-24       Impact factor: 3.046

5.  Human apolipoprotein E2, E3, and E4 isoform-specific transgenic mice: human-like pattern of glial and neuronal immunoreactivity in central nervous system not observed in wild-type mice.

Authors:  P T Xu; D Schmechel; T Rothrock-Christian; D S Burkhart; H L Qiu; B Popko; P Sullivan; N Maeda; A M Saunders; A D Roses; J R Gilbert
Journal:  Neurobiol Dis       Date:  1996       Impact factor: 5.996

6.  Different mechanisms of apolipoprotein E isoform-dependent modulation of prostaglandin E2 production and triggering receptor expressed on myeloid cells 2 (TREM2) expression after innate immune activation of microglia.

Authors:  Xianwu Li; Kathleen S Montine; C Dirk Keene; Thomas J Montine
Journal:  FASEB J       Date:  2015-01-15       Impact factor: 5.191

Review 7.  Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature.

Authors:  Peter T Nelson; Irina Alafuzoff; Eileen H Bigio; Constantin Bouras; Heiko Braak; Nigel J Cairns; Rudolph J Castellani; Barbara J Crain; Peter Davies; Kelly Del Tredici; Charles Duyckaerts; Matthew P Frosch; Vahram Haroutunian; Patrick R Hof; Christine M Hulette; Bradley T Hyman; Takeshi Iwatsubo; Kurt A Jellinger; Gregory A Jicha; Enikö Kövari; Walter A Kukull; James B Leverenz; Seth Love; Ian R Mackenzie; David M Mann; Eliezer Masliah; Ann C McKee; Thomas J Montine; John C Morris; Julie A Schneider; Joshua A Sonnen; Dietmar R Thal; John Q Trojanowski; Juan C Troncoso; Thomas Wisniewski; Randall L Woltjer; Thomas G Beach
Journal:  J Neuropathol Exp Neurol       Date:  2012-05       Impact factor: 3.685

8.  Dendritic degeneration in neostriatal medium spiny neurons in Parkinson disease.

Authors:  S Zaja-Milatovic; D Milatovic; A M Schantz; J Zhang; K S Montine; A Samii; A Y Deutch; T J Montine
Journal:  Neurology       Date:  2005-02-08       Impact factor: 9.910

9.  APOE ε4 increases risk for dementia in pure synucleinopathies.

Authors:  Debby Tsuang; James B Leverenz; Oscar L Lopez; Ronald L Hamilton; David A Bennett; Julie A Schneider; Aron S Buchman; Eric B Larson; Paul K Crane; Jeffrey A Kaye; Patricia Kramer; Randy Woltjer; John Q Trojanowski; Daniel Weintraub; Alice S Chen-Plotkin; David J Irwin; Jacqueline Rick; Gerard D Schellenberg; G Stennis Watson; Walter Kukull; Peter T Nelson; Gregory A Jicha; Janna H Neltner; Doug Galasko; Eliezer Masliah; Joseph F Quinn; Kathryn A Chung; Dora Yearout; Ignacio F Mata; Jia Y Wan; Karen L Edwards; Thomas J Montine; Cyrus P Zabetian
Journal:  JAMA Neurol       Date:  2013-02       Impact factor: 18.302

10.  Apolipoprotein C-I is an APOE genotype-dependent suppressor of glial activation.

Authors:  Eiron Cudaback; Xianwu Li; Yue Yang; Thomas Yoo; Kathleen S Montine; Suzanne Craft; Thomas J Montine; Christopher Dirk Keene
Journal:  J Neuroinflammation       Date:  2012-08-10       Impact factor: 8.322

View more
  7 in total

1.  Mass synaptometry: High-dimensional multi parametric assay for single synapses.

Authors:  Chandresh R Gajera; Rosemary Fernandez; Nadia Postupna; Kathleen S Montine; Edward J Fox; Dmitry Tebaykin; Michael Angelo; Sean C Bendall; C Dirk Keene; Thomas J Montine
Journal:  J Neurosci Methods       Date:  2018-11-20       Impact factor: 2.390

2.  Multimodal Characterization of the Late Effects of Traumatic Brain Injury: A Methodological Overview of the Late Effects of Traumatic Brain Injury Project.

Authors:  Brian L Edlow; C Dirk Keene; Daniel P Perl; Diego Iacono; Rebecca D Folkerth; William Stewart; Christine L Mac Donald; Jean Augustinack; Ramon Diaz-Arrastia; Camilo Estrada; Elissa Flannery; Wayne A Gordon; Thomas J Grabowski; Kelly Hansen; Jeanne Hoffman; Christopher Kroenke; Eric B Larson; Patricia Lee; Azma Mareyam; Jennifer A McNab; Jeanne McPhee; Allison L Moreau; Anne Renz; KatieRose Richmire; Allison Stevens; Cheuk Y Tang; Lee S Tirrell; Emily H Trittschuh; Andre van der Kouwe; Ani Varjabedian; Lawrence L Wald; Ona Wu; Anastasia Yendiki; Liza Young; Lilla Zöllei; Bruce Fischl; Paul K Crane; Kristen Dams-O'Connor
Journal:  J Neurotrauma       Date:  2018-05-03       Impact factor: 5.269

3.  Viable human brain microvessels for the study of aging and neurodegenerative diseases.

Authors:  Mamatha Damodarasamy; Zin Z Khaing; Jeffrey Hyde; C Dirk Keene; Itay Bentov; William A Banks; May J Reed
Journal:  Microvasc Res       Date:  2021-11-20       Impact factor: 3.514

4.  Mass-tag barcoding for multiplexed analysis of human synaptosomes and other anuclear events.

Authors:  Chandresh R Gajera; Rosemary Fernandez; Kathleen S Montine; Edward J Fox; Dunja Mrdjen; Nadia O Postupna; Christopher Dirk Keene; Sean C Bendall; Thomas J Montine
Journal:  Cytometry A       Date:  2021-04-05       Impact factor: 4.714

5.  Single-synapse analyses of Alzheimer's disease implicate pathologic tau, DJ1, CD47, and ApoE.

Authors:  Thanaphong Phongpreecha; Chandresh R Gajera; Candace C Liu; Kausalia Vijayaragavan; Alan L Chang; Martin Becker; Ramin Fallahzadeh; Rosemary Fernandez; Nadia Postupna; Emily Sherfield; Dmitry Tebaykin; Caitlin Latimer; Carol A Shively; Thomas C Register; Suzanne Craft; Kathleen S Montine; Edward J Fox; Kathleen L Poston; C Dirk Keene; Michael Angelo; Sean C Bendall; Nima Aghaeepour; Thomas J Montine
Journal:  Sci Adv       Date:  2021-12-15       Impact factor: 14.136

6.  Integrated omics analysis reveals sirtuin signaling is central to hepatic response to a high fructose diet.

Authors:  Laura A Cox; Jeannie Chan; Prahlad Rao; Zeeshan Hamid; Jeremy P Glenn; Avinash Jadhav; Vivek Das; Genesio M Karere; Ellen Quillen; Kylie Kavanagh; Michael Olivier
Journal:  BMC Genomics       Date:  2021-12-03       Impact factor: 4.547

7.  Epigenetic clock and methylation studies in vervet monkeys.

Authors:  Anna J Jasinska; Amin Haghani; Joseph A Zoller; Caesar Z Li; Adriana Arneson; Jason Ernst; Kylie Kavanagh; Matthew J Jorgensen; Julie A Mattison; Kevin Wojta; Oi-Wa Choi; Joseph DeYoung; Xinmin Li; Andrew W Rao; Giovanni Coppola; Nelson B Freimer; Roger P Woods; Steve Horvath
Journal:  Geroscience       Date:  2021-09-30       Impact factor: 7.581

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.